Athersys, Inc. (ATHXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 3201 CARNEGIE AVENUE
CLEVELAND, OH 44115-2634
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,03837,40751,54635,04151,05929,316
Cash and cash equivalents9,03837,40751,54635,04151,05929,316
Receivables 716   262739
Other undisclosed current assets3,7818,6203,0152,1306,5191,135
Total current assets:13,53546,02754,56137,17157,84031,190
Noncurrent Assets
Operating lease, right-of-use asset7,8468,960700 
Property, plant and equipment4,2143,6923,1552,8823,0022,206
Other noncurrent assets      197
Other undisclosed noncurrent assets2,1361,5051,2981,613888 
Total noncurrent assets:14,19614,1575,1534,4953,8902,403
TOTAL ASSETS:27,73160,18459,71441,66661,73033,593
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,8434,8372,9771,49611,5255,959
Employee-related liabilities4,1331,7797731,9011,065
Accounts payable27,765   9,1634,469
Accrued liabilities1,0787041,198723461425
Deferred revenue    
Debt      
Deferred revenue and credits771
Other undisclosed current liabilities9,60125,02419,97711,3413,9503,353
Total current liabilities:38,44429,86122,95412,83715,47510,083
Noncurrent Liabilities
Long-term debt and lease obligation:  8,755    
Liabilities, other than long-term debt 13,138 197220 134
Customer advances or deposits134
Deferred revenue 5,199   
Other liabilities   197220  
Operating lease, liability 7,9398,755  
Total noncurrent liabilities: 13,13817,510197220 134
Total liabilities:51,58247,37123,15113,05715,47510,217
Equity
Equity, attributable to parent(23,851)16,36931,36223,27143,11623,376
Common stock18243202160144122
Additional paid in capital632,009599,470527,549440,735416,014373,884
Accumulated other comprehensive income      
Accumulated deficit(655,878)(583,344)(496,389)(417,624)(373,042)(350,630)
Total equity:(23,851)16,36931,36223,27143,11623,376
Other undisclosed liabilities and equity (3,556)5,2015,3383,139 
TOTAL LIABILITIES AND EQUITY:27,73160,18459,71441,66661,73033,593

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues5,3255,5141,4405,63324,2913,708
Revenue, net3,708
Cost of revenue(1,420)(1,427)(890)   
Gross profit:3,9054,0875505,63324,2913,708
Operating expenses(80,914)(91,145)(78,882)(50,423)(48,481)(36,307)
Other undisclosed operating loss    (698)(855)(684)
Operating loss:(77,009)(87,058)(78,332)(45,488)(25,045)(33,283)
Nonoperating income (expense)278103(433)906762314
Gain, foreign currency transaction, before tax      
Other nonoperating income (expense)278103(433)906762314
Interest and debt expense      
Loss from continuing operations before equity method investments, income taxes:(76,731)(86,955)(78,765)(44,582)(24,283)(32,969)
Other undisclosed income from continuing operations before income taxes      728
Loss from continuing operations:(76,731)(86,955)(78,765)(44,582)(24,283)(32,241)
Loss before gain (loss) on sale of properties:(86,955)(78,765)(44,582)(24,283)(32,241)
Net loss:(76,731)(86,955)(78,765)(44,582)(24,283)(32,241)
Other undisclosed net income attributable to parent4,197     
Net loss available to common stockholders, diluted:(72,534)(86,955)(78,765)(44,582)(24,283)(32,241)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(76,731)(86,955)(78,765)(44,582)(24,283)(32,241)
Comprehensive loss:(76,731)(86,955)(78,765)(44,582)(24,283)(32,241)
Other undisclosed comprehensive income, net of tax, attributable to parent4,197     
Comprehensive loss, net of tax, attributable to parent:(72,534)(86,955)(78,765)(44,582)(24,283)(32,241)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: